Deep Track Capital, LP
- SEC CIK
- 0001856083
- 最新申報
- 2026/8/14
2024 年第 3 季持倉
持倉截至 2024/9/30，2024/11/14 申報。只含多頭部位，變化是跟 2024 年第 2 季比股數。
- 持股檔數
- 69
- 較 2024 年第 2 季 +2
- 總值
- $31.3 億
- 較 2024 年第 2 季 −$2.16 億 (−6.5%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| ARGXArgenx SE | SPONSORED ADR | 365,000 | $1.98 億 | 6.3% | −35,000−8.8% | 減碼 | 歷史 |
| DVAXDynavax Technologies Corp | COM NEW | 12,526,486 | $1.40 億 | 4.5% | +1,626,486+14.9% | 加碼 | 歷史 |
| GHGuardant Health, Inc. | COM | 6,000,560 | $1.38 億 | 4.4% | +1,500,560+33.3% | 加碼 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 4,400,654 | $1.27 億 | 4.1% | +1,900,654+76.0% | 加碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 4,347,464 | $1.24 億 | 4.0% | +1,463,728+50.8% | 加碼 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 3,843,900 | $1.23 億 | 3.9% | +143,900+3.9% | 加碼 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 3,282,000 | $1.18 億 | 3.8% | −718,000−18.0% | 減碼 | 歷史 |
| ITCIIntra-Cellular Therapies, Inc. | COM | 1,600,693 | $1.17 億 | 3.7% | +62,771+4.1% | 加碼 | 歷史 |
| OCULOcular Therapeutix, Inc | COM | 12,721,460 | $1.11 億 | 3.5% | 00.0% | 不變 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 4,950,000 | $1.02 億 | 3.2% | +150,000+3.1% | 加碼 | 歷史 |
| ALKSAlkermes plc. | SHS | 3,500,000 | $9,797 萬 | 3.1% | 00.0% | 不變 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 3,180,025 | $9,149 萬 | 2.9% | −819,975−20.5% | 減碼 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 2,200,000 | $8,813 萬 | 2.8% | +200,000+10.0% | 加碼 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 3,868,104 | $8,692 萬 | 2.8% | −123,396−3.1% | 減碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 3,750,945 | $8,533 萬 | 2.7% | −172,904−4.4% | 減碼 | 歷史 |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 3,548,001 | $8,029 萬 | 2.6% | +57,495+1.6% | 加碼 | 歷史 |
| MBXMBX Biosciences, Inc. | COM | 3,018,935 | $7,843 萬 | 2.5% | +3,018,935 | 新進 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 857,219 | $7,704 萬 | 2.5% | −995,565−53.7% | 減碼 | 歷史 |
| PLRXPliant Therapeutics, Inc. | COM | 5,972,257 | $6,695 萬 | 2.1% | 00.0% | 不變 | 歷史 |
| APGEApogee Therapeutics, Inc. | COM | 1,000,000 | $5,874 萬 | 1.9% | 00.0% | 不變 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 15,272,172 | $5,544 萬 | 1.8% | 00.0% | 不變 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 1,220,508 | $5,357 萬 | 1.7% | +270,508+28.5% | 加碼 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 4,000,000 | $4,776 萬 | 1.5% | 00.0% | 不變 | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 5,576,558 | $4,651 萬 | 1.5% | −523,442−8.6% | 減碼 | 歷史 |
| FDMT4D Molecular Therapeutics, Inc. | COM | 4,096,452 | $4,428 萬 | 1.4% | +35,051+0.9% | 加碼 | 歷史 |
| ABVXAbivax S.A. | SPONSORED ADS | 3,579,209 | $4,123 萬 | 1.3% | −600,554−14.4% | 減碼 | 歷史 |
| TGTXTG Therapeutics, Inc. | COM | 1,725,000 | $4,035 萬 | 1.3% | −1,145,131−39.9% | 減碼 | 歷史 |
| DFTXDefinium Therapeutics, Inc. | Stock | 7,065,099 | $4,020 萬 | 1.3% | +961,282+15.7% | 加碼 | 歷史 |
| KURAKura Oncology, Inc. | COM | 1,963,505 | $3,837 萬 | 1.2% | +1,578,749+410.3% | 加碼 | 歷史 |
| GERNGeron Corp | COM | 7,575,049 | $3,439 萬 | 1.1% | −5,424,951−41.7% | 減碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 629,906 | $3,326 萬 | 1.1% | +497,411+375.4% | 加碼 | 歷史 |
| ORKAOruka Therapeutics, Inc. | COM | 1,235,187 | $3,027 萬 | 1.0% | +1,235,187 | 新進 | 歷史 |
| ANIPAni Pharmaceuticals Inc | COM | 504,828 | $3,012 萬 | 1.0% | +38,739+8.3% | 加碼 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 1,000,000 | $2,941 萬 | 0.9% | −756,667−43.1% | 減碼 | 歷史 |
| EWTXEdgewise Therapeutics, Inc. | COM | 1,100,536 | $2,937 萬 | 0.9% | +914,150+490.5% | 加碼 | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 600,326 | $2,841 萬 | 0.9% | −899,674−60.0% | 減碼 | 歷史 |
| KRROKorro Bio, Inc. | COM | 850,000 | $2,841 萬 | 0.9% | +79,355+10.3% | 加碼 | 歷史 |
| Avidity Biosciences, Inc.05370A108 | COM | 475,000 | $2,182 萬 | 0.7% | +475,000 | 新進 | – |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,350,000 | $2,159 萬 | 0.7% | +1,350,000 | 新進 | 歷史 |
| ALECAlector, Inc. | COM | 4,631,998 | $2,159 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| NKTRNektar Therapeutics | COM | 15,922,655 | $2,070 萬 | 0.7% | −1,952,843−10.9% | 減碼 | 歷史 |
| ETNB89bio, Inc. | COM | 2,766,512 | $2,047 萬 | 0.7% | +472,501+20.6% | 加碼 | 歷史 |
| BCAXBicara Therapeutics Inc. | COM | 796,852 | $2,030 萬 | 0.6% | +796,852 | 新進 | 歷史 |
| AKROAkero Therapeutics, Inc. | COM | 689,784 | $1,979 萬 | 0.6% | +689,784 | 新進 | 歷史 |
| FATEFate Therapeutics Inc | COM | 5,572,607 | $1,950 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| SLNSilence Therapeutics plc | ADS | 1,000,000 | $1,818 萬 | 0.6% | −359,745−26.5% | 減碼 | 歷史 |
| ENGNenGene Therapeutics Inc. | COM | 2,607,633 | $1,721 萬 | 0.5% | +357,633+15.9% | 加碼 | 歷史 |
| EDITEditas Medicine, Inc. | COM | 4,900,334 | $1,671 萬 | 0.5% | −1,099,666−18.3% | 減碼 | 歷史 |
| XNCRXencor Inc | COM | 800,000 | $1,609 萬 | 0.5% | +800,000 | 新進 | 歷史 |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 4,184,100 | $1,536 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| CNTXContext Therapeutics Inc. | COM | 7,419,355 | $1,454 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| HELPCybin Inc. | COM NEW | 1,529,987 | $1,360 萬 | 0.4% | +1,529,987 | 新進 | 歷史 |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 3,283,783 | $1,333 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| IVVDInvivyd, Inc. | COM | 10,953,937 | $1,117 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| CLYMClimb Bio, Inc. | COM | 2,169,143 | $1,104 萬 | 0.4% | −1,735,642−44.4% | 減碼 | 歷史 |
| INOInovio Pharmaceuticals, Inc. | COM SHS | 1,804,366 | $1,043 萬 | 0.3% | −262,354−12.7% | 減碼 | 歷史 |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 967,000 | $918.6 萬 | 0.3% | +967,000 | 新進 | 歷史 |
| NMRANeumora Therapeutics, Inc. | COM | 567,428 | $749.6 萬 | 0.2% | +567,428 | 新進 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 531,857 | $744.1 萬 | 0.2% | −6,838,143−92.8% | 減碼 | 歷史 |
| VIGLVigil Neuroscience, Inc. | COM | 1,553,996 | $528.4 萬 | 0.2% | +956,781+160.2% | 加碼 | 歷史 |
| RGLSRegulus Therapeutics Inc. | COM | 3,262,564 | $512.2 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ALLKAllakos Inc. | COM | 5,000,000 | $326.6 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ANROAlto Neuroscience, Inc. | COM SHS | 219,648 | $251.3 萬 | 0.1% | −292,038−57.1% | 減碼 | 歷史 |
| PRTAProthena Corp Public Ltd Co | SHS | 140,000 | $234.2 萬 | 0.1% | +140,000 | 新進 | 歷史 |
| RLMDRelmada Therapeutics, Inc. | COM | 674,833 | $218.6 萬 | 0.1% | −559,940−45.3% | 減碼 | 歷史 |
| ALGSAligos Therapeutics, Inc. | COM NEW | 244,110 | $211.4 萬 | 0.1% | 00.0% | 不變依 1 比 25 拆股換算 | 歷史 |
| SYRSSyros Pharmaceuticals, Inc. | COM NEW | 828,485 | $178.1 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| MGXMetagenomi Therapeutics, Inc. | COM | 307,500 | $66.7 萬 | <0.1% | −158,732−34.0% | 減碼 | 歷史 |
| SRRKScholar Rock Holding Corp | COM | 48,100 | $38.5 萬 | <0.1% | −324,459−87.1% | 減碼 | 歷史 |
選擇權（2 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2024 年第 2 季之後清倉（9 檔）
2024 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2024 年第 2 季股數 | 2024 年第 2 季市值 | 2024 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| AMGNAmgen Inc | Stock | 575,000 | $1.80 億 | 5.4% | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 2,000,000 | $1.34 億 | 4.0% | 歷史 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 500,000 | $1.22 億 | 3.6% | 歷史 |
| HLVXHilleVax, Inc. | COM | 1,832,652 | $2,650 萬 | 0.8% | 歷史 |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 389,546 | $1,611 萬 | 0.5% | 歷史 |
| Cybin Ord23256X100 | COM | 58,139,535 | $1,576 萬 | 0.5% | – |
| AGENAgenus Inc | COM NEW | 313,359 | $524.9 萬 | 0.2% | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 904,261 | $298.4 萬 | 0.1% | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 308,235 | $259.8 萬 | 0.1% | 歷史 |